| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8630dc49e2bc3e2afca9580a109f47e5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C277-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 |
| filingDate |
2020-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3c3821c7f2d3bf4996bd27077b745ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5710e992827a0879b6f5b3df76dd2d8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf6541dad0ae192937441b8aeb97273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335b590f8b59310d06132893a28768b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e6ef8996ac50852e7a0a58d3991417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c02f886b27cfde912890eaf7ed9ead |
| publicationDate |
2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114341103-A |
| titleOfInvention |
Aminoguanidine hydrazones as antiporter stabilizers useful in the treatment of neurological diseases |
| abstract |
The present invention relates to novel aminoguanidine hydrazone derivatives which are effective as antiporter stabilizers and as neuroprotective drugs. The present invention also relates to pharmaceutical compositions comprising the same and their use in therapy and diagnosis. |
| priorityDate |
2019-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |